Extension of Option Exercise Period

Summary by AI BETAClose X

Scancell Holdings plc announced an extension of the exercise period for 3.85 million share options awarded to its Chief Scientific Officer, Lindy Durrant, from July 30, 2026, to January 31, 2027, with an exercise price of 4.5 pence per share. This extension is considered a related party transaction, and the independent Directors, in consultation with the Company's nominated adviser, deem it fair and reasonable for shareholders.

Disclaimer*

UK 100

Latest directors dealings